Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / FREQ - Frequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 Results


FREQ - Frequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 Results

  • Frequency Therapeutics is using novel progenitor cell stimulating technology to regrow hair cells in the ear and improve hearing loss in patients.
  • Progenitor cells are found all throughout the body, so if successful, Frequency's technology should be broadly extendable into other areas.
  • With Phase 2 results expected in Q1 2021, Frequency could see substantial de-risking and possibly a meaningfully higher share price to go along with it.

For further details see:

Frequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 Results
Stock Information

Company Name: Frequency Therapeutics Inc.
Stock Symbol: FREQ
Market: NYSE

Menu

FREQ FREQ Quote FREQ Short FREQ News FREQ Articles FREQ Message Board
Get FREQ Alerts

News, Short Squeeze, Breakout and More Instantly...